Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Current Hematologic Malignancy Reports|August 27, 2013
Management of double-refractory multiple myelomaJason P Meadows, Tomer M MarkOncotargets and Therapy|June 28, 2014
Potential role of daratumumab in the treatment of multiple myelomaYulian Khagi, Tomer M MarkFuture Oncology (London, England)|July 11, 2013
Pomalidomide in the treatment of relapsed multiple myelomaPeter A Forsberg, Tomer M MarkCurrent Hematologic Malignancy Reports|August 16, 2015
Novel Induction Regimens in Multiple MyelomaKarie D Runcie, Tomer M MarkCurrent Oncology (Toronto, Ont.)|July 25, 2022
Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging TherapiesMargaret E Stalker, Tomer M MarkLeukemia Research|April 3, 2014
Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myelomaTomer M Mark, Morton Coleman, Ruben NiesvizkyClinical Lymphoma, Myeloma & Leukemia|July 24, 2017
Monoclonal Antibodies in Multiple Myeloma: A New Wave of the FutureDaniel W Sherbenou, Tomer M Mark, Peter ForsbergCurrent Hematologic Malignancy Reports|August 23, 2014
Controversies in multiple myeloma: to transplant or not?Isabel Ruth Preeshagul, Koen Van Besien, Tomer M MarkPulmonary Circulation|September 25, 2015
Pulmonary hypertension complicating multiple myelomaUdhay Krishnan, Tomer M Mark, Ruben Niesvizky, et al.Critical Reviews in Oncology/Hematology|June 22, 2013
Pomalidomide: new immunomodulatory agent with potent antiproliferative effectsPaul G Richardson, Tomer M Mark, Martha Q LacyPageof 5